PPA
SCMP

Parametric Portfolio Associates’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Parametric Portfolio Associates’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-112,074
Closed -$2.01M – 4005
2017
Q4 		$2.01M Buy
112,074
+6,733
+6% +$82.9K ﹤0.01% 2601
2017
Q3 		$1.24M Buy
105,341
+49,856
+90% +$559K ﹤0.01% 2905
2017
Q2 		$583K Buy
55,485
+21,574
+64% +$220K ﹤0.01% 3274
2017
Q1 		$373K Sell
33,911
-27,764
-45% -$322K ﹤0.01% 3343
2016
Q4 		$836K Buy
61,675
+13,172
+27% +$184K ﹤0.01% 2939
2016
Q3 		$597K Buy
48,503
+33,058
+214% +$390K ﹤0.01% 3087
2016
Q2 		$169K Sell
15,445
-2,231
-13% -$25K ﹤0.01% 3647
2016
Q1 		$193K Sell
17,676
-3,548
-17% -$44.8K ﹤0.01% 3752
2015
Q4 		$367K Buy
21,224
+2,214
+12% +$39.7K ﹤0.01% 3448
2015
Q3 		$378K Sell
19,010
-4,178
-18% -$95.8K ﹤0.01% 2856
2015
Q2 		$381K Buy
23,188
+582
+3% +$10.1K ﹤0.01% 3437
2015
Q1 		$352K Sell
22,606
-802
-3% -$12.4K ﹤0.01% 3471
2014
Q4 		$334K Sell
23,408
-3,245
-12% -$34.3K ﹤0.01% 3489
2014
Q3 		$173K Buy
+26,653
New +$177K ﹤0.01% 3648
2014
Q2 		– Sell
-27,154
Closed -$194K – 3841
2014
Q1 		$194K Buy
27,154
+3,680
+16% +$31.5K ﹤0.01% 3639
2013
Q4 		$221K Hold
23,474
– – ﹤0.01% 3574
2013
Q3 		$146K Sell
23,474
-401
-2% -$2.5K ﹤0.01% 3671
2013
Q2 		$157K Buy
+23,875
New +$189K ﹤0.01% 3531

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Parametric Portfolio Associates's SCMP Position: Q1 2018 in Review

Parametric Portfolio Associates sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 112,074 shares — an estimated $2.01M sold.

Parametric Portfolio Associates first reported a position in SCMP in Q2 2013 and held it in 18 quarters. The position peaked at $2.01M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Parametric Portfolio Associates reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parametric Portfolio Associates sold 112,074 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2.01M.
  • Parametric Portfolio Associates first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Parametric Portfolio Associates's Sucampo Pharmaceuticals, Inc. position peaked at $2.01M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Parametric Portfolio Associates's 13F filing for Q1 2018, filed 14 May 2018.